Additionally, they demonstrated high-affinity binding to MDM2 (KD = 1.32 μM and 1.72 μM) and significantly downregulated BCL2 gene and protein expression in cancer cells, reinforcing their mechanism of inducing apoptosis through dual targeting of the p53 and BCL2 pathways. Here, MDM2 is linked to cancer.